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Abstract
Background: The urokinase plasminogen activator receptor associated protein (uPARAP)/
Endo180 is a novel endocytic receptor that mediates collagen uptake and is implicated to play a
role in physiological and pathological tissue-remodelling processes by mediating intracellular
collagen degradation.
Result: This study investigates the expression of uPARAP/Endo180 protein and messenger RNA
in primary rat hepatic stellate cell (HSC) cultures. The results show that uPARAP/Endo180 protein
is not expressed in freshly isolated HSCs or during the first few days of culture while the cells still
display quiescent features. In contrast, uPARAP/Endo180 protein is expressed early during HSC
activation when cells are transdifferentiated into myofibroblast-like cells. Very low levels of
uPARAP/Endo180 mRNA are detectable during the first days of culture but uPARAP/Endo180
mRNA is strongly up-regulated with increasing time in culture. Moreover, endocytic uptake of
denatured collagen increases as transdifferentiation proceeds over time and correlates with
increased expression of uPARAP/Endo180. Finally, analysis of uPARAP/Endo180 expression in four
hepatic stellate cell lines from three different species showed that all these cell lines express
uPARAP/Endo180 and are able to take up denatured collagen efficiently.
Conclusion: These results demonstrate that uPARAP/Endo180 expression by rat HSCs is strongly
up-regulated during culture activation and identify this receptor as a feature common to culture-
activated HSCs.
Background
The urokinase plasminogen activator receptor associated
protein (uPARAP)/Endo180 (also known as CD280;
referred to hereafter as Endo180) is an endocytic receptor
which together with the mannose receptor, the M-type
phospholipase A2 receptor and the dendritic cell receptor
DEC-205 constitutes the mannose receptor family of C-
type lectins [1-3]. Endo180 was discovered as a constitu-
tively recycling receptor of unknown function with a
molecular mass of 180 kDa [4], and subsequently identi-
fied as a transcript of a gene encoding a novel member of
the mannose receptor family of C-type lectins [5]. It was
later recognized as a collagen-binding receptor and was
referred to as urokinase plasminogen activator (uPA)
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its ability to form a ternary complex on the cell surface
with uPA and its receptor uPAR [6]. Further work has
established that Endo180 can act as an endocytic receptor
to mediate the uptake and degradation of both native and
denatured collagens through clathrin-dependent endocy-
tosis. Endo180 may have a role in the catabolism of extra-
cellular matrix (ECM) collagen [7-15]. Recent studies
suggest that Endo180 can also exert functions beyond
endocytosis of collagen including cell-matrix adhesion
and cell migration [8,14,16,17].
Hepatic stellate cells (HSCs), located in the space of Disse,
are the main storage site for vitamin A (in the form of ret-
inyl ester-containing lipid droplets) in the body and they
also contribute to the production of ECM proteins [18-
20]. In normal liver, HSCs are essentially quiescent, but
have the ability to transdifferentiate into myofibroblast-
like cells in response to liver injury during a process
termed "activation" [21].
Liver injury can occur as a consequence of a wide variety
of causes including T cell-mediated response to viral infec-
tion, toxic metabolites from ethanol metabolism, and
autoimmune hepatitis [21-24]. Activation of HSCs repre-
sents a key process in a wound healing program initiated
in response to such injuries. Responding to paracrine
stimuli such as transforming growth factor-β1, platelet
derived growth factor, insulin-like growth factor and/or to
material released from necrotic/apoptotic hepatocytes,
quiescent HSCs undergo changes in gene expression,
down-regulating genes involved in the preservation of the
quiescent state while up-regulating genes that promote
HSC myofibroblastic functions and thereby hepatic tissue
remodelling. They acquire a fibrogenic phenotype leading
to enhanced production and secretion of ECM compo-
nents. They also produce and secrete matrix metallopro-
teinases (MMPs) that degrade excess of ECM and
inhibitors that limit the action of MMPs. Moreover, HSCs
loose their vitamin A contents and acquire myofibroblas-
tic properties including contractility which are important
for vasoregulation and wound closure [21,25-30].
Culturing of HSCs isolated from normal livers on tissue
culture plastic will also cause activation of quiescent HSCs
and their transdifferentiation into proliferating myofi-
broblastic cells, features similar to those observed in HSCs
activated in vivo [31,32]. We have previously shown that
Endo180 expressed by culture-activated rat HSCs is the
main receptor in these cells mediating endocytosis of
denatured collagen [13]. In this report, we used this cell
culture system to investigate the expression of Endo180 in
the primary culture of rat HSCs to see whether Endo180 is
expressed constitutively by quiescent HSCs or if it is a
component in the transdifferentiation program that is
induced during the course of the activation process.
Results
Morphological and marker characterization of HSCs in 
primary culture
After 40 hours in primary culture, the cells showed homo-
geneous stellate morphology with extended long proc-
esses. Oil Red-O staining showed that more than 98% of
cells possess variable amounts of lipid droplets and clear
nuclei (Figure 1A). All of these features are considered as
phenotypic landmarks of the majority, but not all, of qui-
escent HSCs [33]. After 3–4 days of culture, the cells
exhibited heterogeneous morphology suggestive of acti-
vating HSCs, e.g., cells in the transition from the quiescent
to activated phenotype (not shown). After 6–7 days, lipid
droplets were less abundant and most cells adopted mor-
phology typical of activated HSCs: large, spread out,
polygonal morphology similar to myofibroblastic cells
(Figure 1B). Most cells sub-cultured for 5 days displayed
myofibroblastic appearance and were devoid of lipid
droplets (Figure 1C).
Cultured HSCs were also characterized by the expression
of quiescent and activation protein markers using Western
blotting. The intermediate filament desmin is expressed in
quiescent rat HSCs and is maintained during activation
[34,35]. Quiescent rat HSCs also express glial fibrillary
acidic protein (GFAP), another intermediate filament pro-
tein [36,37], but down-regulate this marker when they
transdifferentiate into myofibroblasts [37-41]. In con-
trast, HSCs in the quiescent state do not express smooth
muscle α-actin (α-SMA), a cytoskeletal protein important
for contractile activity of myofibroblasts, but induce its
expression when they acquire an activated phenotype
[42,43]. In this study, we used these markers to confirm
the identity of HSCs during culture activation. As
expected, desmin expression was high in freshly isolated
cells and significant expression was also maintained in
activated state. Expression of GFAP was also high in
freshly isolated and activating HSCs but was down-regu-
lated in fully activated cells. Smooth muscle α-actin was
absent from freshly isolated HSCs but its expression was
rapidly induced during the first few days of culture (see
Figure 2A and 2B).
Changes in Endo180 protein and mRNA levels during rat 
HSC activation in vitro
We first examined the expression of Endo180 protein by
Western blot analysis using lysates prepared from freshly
isolated and cultured HSCs 1–7 days after plating. No
band corresponding to Endo180 was detected in lysates
from freshly isolated cells and cultured cells during the
first three days. However, a band corresponding to
Endo180 (approximately 180 kDa) was detectable by dayPage 2 of 11
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fold in the following two days and remained unchanged
thereafter (Fig 2A and 2B). In one of seven separate isola-
tions the 180-kDa band was detected weakly in 3-day cul-
tured HSCs. The human U937 monocytic cell line and
non-parenchymal cells prepared from rat liver were used
as positive and negative controls, respectively, for the
expression of Endo180 (Fig 2B). No bands were detected
when a non-specific rabbit immunoglobulin G was used
(data not shown). To determine whether the increased
Endo180 protein expression was paralleled by increase in
mRNA expression, we examined the expression of
Endo180 by RT-PCR of total RNA. Very low levels of
Endo180 mRNA were detectable in freshly isolated HSCs
and cultured cells during the first two days. However, cul-
turing of cells for three days resulted in a strong up-regu-
lation of Endo180 mRNA expression. Maximal up-
regulation was observed between days 5 and 6 (Fig. 2D).
Up-regulation of Endo180 correlates with increased 
uptake of denatured collagen
We previously showed that the polyclonal anti-Endo180
antibody employed in this study is able to inhibit both
cell-surface binding and endocytosis of denatured colla-
gen by culture-activated rat HSCs [13]. To determine
whether increased expression of Endo180 in cultured
HSCs results in increased uptake of denatured collagen,
cultured HSCs at different time points were assayed for
their ability to take up and degrade denatured collagen. To
this end, we used 125I-TC-labeling of denatured collagen,
which has the advantage that the released 125I-TC (after
degradation of ligand) is trapped in intracellular compart-
ments and both internalization and degradation can
directly be measured in cell lysates. The results showed a
parallel increase in the uptake of 125I-TC-collagen and
expression of Endo180 as the cells became more activated
(Fig. 3A). Activated HSCs also showed a significant
increase in their capacity to degrade the internalized 125I-
TC-collagen from an average 5.1% (of internalized) in 4-
day cells to 15% in activated cells (7-day cells) and to 22%
in sub-cultured cells (Fig. 3B).
Incubation of cells in the presence of a 100-fold excess of
unlabeled denatured collagen for 30 min at 37°C resulted
in significant inhibition of the uptake of 125I-TC-collagen,
indicating receptor-mediated internalization from the cell
surface (Fig. 3C). The degradation of 125I-TC-collagen was
significantly reduced in E64d-treated cells, by ~67%, indi-
cating the involvement of cysteine proteases in the degra-
dation of internalized ligand. The total uptake was not
affected by E64d, indicating that receptor endocytic traf-
ficking was normal (Fig. 3C). Incubating cells with conca-
namycin A, a drug that inhibits the activity of the vacuolar
proton pump, inhibited the degradation of 125I-TC-colla-
gen by ~84%, indicating that degradation of internalized
Light microscopic analysis of HSCs stained with Oil Red-O at d fferent stages of tr nsdifferentiation in primary cultureFi ure 1
Light microscopic analysis of HSCs stained with Oil 
Red-O at different stages of transdifferentiation in 
primary culture. (A) Representative micrographs of HSCs 
cultured for 40 hours (A), 7 days (B) or sub-cultured for 5 
days (C) showing changes in the morphology (from stellate 
shape to myofibroblast-like cells) and contents of lipid drop-
lets. Note that HSCs cultured for 40 h contain variable 
amounts of lipid droplets. In sub-cultured (first passage) cells, 
there were no detectable lipid droplets as judged by Oil Red-
O staining (data not shown). Original magnification: ×100. 
The micrographs shown are representative of cells obtained 
from at least two different preparations.Page 3 of 11
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Time course analysis of the expression of Endo180 and marker proteins in freshly isolated and cultured rat HSCsF gure 2
Time course analysis of the expression of Endo180 and marker proteins in freshly isolated and cultured rat 
HSCs. (A and B) Western blot analysis of expression of Endo180, desmin, GFAP, and α-SMA during culture activation of rat 
HSCs. At the time points shown cells were collected and cell lysates were prepared from frozen cell pellets (A) or cells were 
lysed directly in lysis buffer (B) and the same amount of proteins was analyzed by SDS-PAGE and Western blot using anti-
Endo180 antibody. The blots were re-probed with antibodies to β-actin, used as a loading control, and marker proteins as indi-
cated. Total non-parenchymal cells (NPC) were prepared from rat liver by collagenase perfusion as previously described [59]. 
(C) Densitometric analysis of Western blots showing the time-dependent increase in Endo180 protein expression in cultured 
rat HSCs. The ratio Endo180/β-actin bands was quantified for each day and expressed as means ± SD of seven different sam-
ples (days 1–5, and 7) or four different samples (days 0, 6 and sub-cultured). Note that there is less beta-actin in the three first 
lanes in Fig. 2A. However, densitometric analysis of bands showed that the amount of beta-actin at day 3 is ~ twice as much as 
day 7, yet no expression of Endo180 is observed at day 3. (D) RT-PCR analysis of Endo180 mRNA expression during culture 
activation of rat HSCs. Total RNA was extracted from cells and Endo180 and β-actin, used as an internal control, mRNAs 
were analyzed by RT-PCR. One representative experiment (out of three independent experiments) is shown. SC, sub-cultured 
(first passage).
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lysosomes). However, the total uptake was also reduced,
by ~25%, by this treatment (Fig. 3C), probably due to the
continuous recycling and re-internalization of ligand-
occupied receptors, which prevent them from participat-
ing in further rounds of ligand uptake [44]. Taken
together, these results suggest that the up-regulation of
Endo180 in rat HSCs is associated with an increased abil-
ity of cells to take up and degrade denatured collagen. Fur-
thermore, the data suggest that culture-activation of HSCs
is associated with an enhanced capacity to degrade the
internalized ligand, which may reflect enhanced lyso-
somal activity. Alternatively, the rate of ligand delivery to
lysosomes may be faster in activated rat HSCs than in
non-activated HSCs.
Human and rodent HSC lines express Endo180
To see if the expression of Endo180 in activated rat HSCs
is restricted to our cell culture system or common to other
culture-activated HSCs, we investigated whether Endo180
is present in four established hepatic stellate cell lines
from three different species: the human LX-2 cells, the
murine HSC line M1-4, and two rat HSC lines, BSC, and
MFBY2.
As shown in Figure 4A and 4B, Endo180 protein and
mRNA are expressed by all of these cell lines. However,
the antibody against the Endo180 recognized two bands
in the total cell lysate from M1-4 cells, one with a slightly
higher molecular weight, probably due to different
degrees of glycosylation of the Endo180 protein.
Furthermore, all four of these cell lines were able to take
up and degrade 125I-TC-collagen (Figure 4C), although
some differences in the endocytic and degradative capaci-
ties between these cell lines were noted. The murine M1-4
HSC line was more active in endocytosis and could take
up approximately 1.6- and 2.7-fold more 125I-TC-collagen
than rat and human HSC lines, respectively, during a 2-h
incubation at 37°C. Despite a higher endocytic capacity,
the murine M1-4 cells degraded the internalized collagen
very inefficiently: only about 10% of the total internalized
collagen was degraded by these cells during 2 h, which is
comparable to the amount of internalized collagen
degraded by the human LX-2 cells. By comparison, both
rat HSC lines degraded the internalized collagen with
comparable efficiencies; about 30% of the internalized,
during the same incubation time (Figure 4D).
Discussion
In this study, using primary rat HSCs, we demonstrate that
(1) whereas no Endo180 protein expression was observed
in freshly isolated HSCs or during the first 3 days of cul-
ture, Endo180 protein was consistently detectable after 4
days in culture, and increased further during the following
days, (2) low levels of Endo180 mRNA were detectable in
isolated HSCs during the first two days of culture. How-
ever, a strong up-regulation of Endo180 mRNA expres-
sion in cells after 3 days in culture was further enhanced
with increasing time in culture, (3) the increase in
Endo180 protein levels ran parallel with a corresponding
increase in HSC uptake of denatured collagen, (4) activa-
tion of rat HSCs was associated with enhanced degrada-
tion of internalized collagen, and (5) Endo180 is
expressed by both human and rodent hepatic stellate cell
lines. These findings have not been described previously.
We cannot, however, rule out the possibility that
Endo180 mRNA might be expressed at very low levels by
the majority of quiescent HSCs or at higher levels by a
minor subset of quiescent HSCs.
The increase in the ability of HSCs to endocytose collagen
was strikingly similar to the increase in expression of
Endo180, as transdifferentiation proceeded over time.
This relation between endocytic activity and receptor
expression, which was also seen in established hepatic cell
lines, supports earlier observations indicating that
Endo180 is the main and maybe the only receptor medi-
ating endocytosis of collagen in activated HSCs [13].
The functional importance of culture-induced up-regula-
tion of Endo180 in the setting of liver injury is not clear at
present. However, Endo180, if expressed by activated
HSCs in injured livers, may have several potential func-
tions in hepatic wound healing. The MMP-mediated
cleavage of the fibrillar collagens results in the production
of fragments which are rapidly denatured. Although colla-
gen fragments thus formed can be further degraded by
gelatinases [45,46], receptor-mediated endocytosis and
lysosomal degradation of internalized collagen fragments
by Endo180-expressing cells may also play a role in regu-
lating the extracellular levels of collagens during tissue
remodelling. Indeed, a recent study showed that collagen
fragments generated by collagenase activity and heat-
denatured collagen are taken up much more efficiently
than intact collagen by Endo180-expressing cells [12].
Findings showing that Endo180 is highly expressed in tis-
sues undergoing active ECM remodelling (such as during
embryological development [5,47], during early postnatal
bone and cartilage growth [9,48], and during gingival
wound healing [49]) also points to its essential role in
degradation of ECM. Moreover, several studies have
shown that up-regulation of Endo180 in tumour cells [50]
and stromal cells such as myofibroblasts is highly corre-
lated with the malignancy of various carcinomas [51-53],
and there is further evidence that Endo180-mediated col-
lagen clearance accounts for tumour progression
[50,51,53]. Endo180 expressed by activated HSCs may
also play a role in promoting tumour invasion in the liver,
given the fact that activated HSCs are a component of thePage 5 of 11
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Uptake and degradation of denatured collagen by rat HSCs as a function of cell culture time and the effect of inhibitors of lyso-somal function on these processesFigur 3
Uptake and degradation of denatured collagen by rat HSCs as a function of cell culture time and the effect of 
inhibitors of lysosomal function on these processes. (A) At each day, cells cultured in 6-well plates were washed, pre-
incubation for 45 min at 37°C, and then incubated for 2 h at 37°C with 10 μg/ml 125I-TC-collagen. After washing, cells were 
lysed to determine total cell-associated radioactivity (= the sum of acid-soluble and acid-precipitable radioactivity), which was 
taken as a measure of total uptake of 125I-TC-collagen. Acid-soluble radioactivity was taken as a measure of degradation of 125I-
TC-collagen. (B) The calculated percentage of internalized 125I-TC-collagen degraded by cells. Results are shown as means ± 
SD for triplicate wells and represent one of three similar experiments. Data are normalized for cell number. Cells were 
counted on the indicated days as described in Materials and methods. (C) Sub-cultured (first passage) HSCs were washed, pre-
incubation for 45 min at 37°C, and then incubated at 37°C with 125I-TC-collagen for either 30 min in the absence or presence 
of excess unlabeled denatured collagen (100-fold) or for 2 h in the absence or presence of E64d (100 μM) or concanamycin A 
(Con A, 1.5 μM). Uptake and degradation were determined as described above. Data represent either average of duplicate 
determinations (unlabeled collagen) or means ± SD for triplicate determinations (E64d and Con A) and are representative for 
at least two such experiments performed.
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to the tumour progression [54-56].
Conclusion
The present study has identified Endo180 as a protein that
is up-regulated in association with HSC activation during
primary culture. These in vitro data suggest that Endo180
may play a role in matrix collagen turnover. In addition,
Endo180 could be a good marker of culture-activated
HSCs. Further investigation will be required to determine
if Endo180 expression is similarly up-regulated by acti-
vated HSCs in the context of liver injury.
Methods
Materials
Polyclonal rabbit anti-Endo180 antibody was a gift from
Dr. Clare M. Isacke (Breakthrough Breast Cancer Research
Centre, The Institute of Cancer research, London, UK).
This polyclonal antiserum was initially raised against
purified human Endo180 [4] and we have previously
shown that it also reacts with rat Endo180 [13]. Anti-
desmin antibody (Cat. No. D-1033, mouse monoclonal),
anti-α smooth muscle actin antibody (Cat. No. A-2547,
mouse monoclonal), anti-glial fibrillary acidic protein
antibody (Cat. No. G-2969, rabbit polyclonal), and anti-
β-actin antibody (Cat. No. A-5316, mouse monoclonal)
were obtained from Sigma. Secondary horseradish perox-
idase-conjugated antibodies were obtained from GE
Healthcare. Collagenase H, DNase I and protease inhibi-
tors were obtained from Roche. Pronase E was obtained
from MERCK. Culture media and Hank's balanced salt
solution were from Gibco BRL (Invitrogen). Fetal bovine
serum (Cat. No. A15-151) was obtained from PAA Labo-
ratories GmbH. Antibiotics were obtained from BioWhit-
taker. Bovine serum albumin, collagen from calf skin
(Cat. No. C-3511), and Optiprep (60% w/v) were
obtained from Sigma. All other chemicals and reagents
were obtained from Sigma unless otherwise specified.
Preparation and culture of hepatic stellate cells
Animals received human care according to the guidelines
of University of Oslo. Male Wistar rats, weighing 650 to
800 g, were used in experiments. HSCs were prepared by
in situ pronase/collagenase perfusion at 37°C and density
gradient centrifugation as described [57] with some mod-
ifications. Briefly, the animal was anesthetized with
pentobarbital and the liver was perfused via the portal
vein for about 10 min with calcium-free/magnesium-free
Hank's balanced salt solution (HBSS) without phenol red.
The liver was then removed and perfused with 0.35% pro-
nase in HBSS containing calcium and magnesium and
phenol red for about 20 min. This was followed by per-
fusion in a re-circulating system with a mixture of 0.035%
collagenase and 0.1% pronase in HBSS for 20 min. There-
after, the digested liver was suspended in HBSS containing
0.015% DNase and filtered through a sterile 100 μm
nylon mash. The filtered suspension was divided in four
50-ml centrifuge tubes and centrifuged at 540 × g at 14°C
for 7 min. The pellets were then re-suspended in HBSS
containing DNase and centrifuged as described above.
This was repeated once and the pellets of non-parenchy-
mal cells were pooled and re-suspended in HBSS. The cell
suspension was then mixed with 29% Optiprep solution
in HBSS (to give 11.6% Optiprep), divided in two 50-ml
centrifuge tubes and then overlaid with 5 ml HBSS con-
taining 1% BSA and centrifuged at 1400 × g at 14°C for 23
min in a Eppendorf centrifuge (5810 R), without brake.
After centrifugation, the interface layer was collected and
washed twice in HBSS. After washing, the cells were re-sus-
pended in Dulbecco's Minimum Essential medium
(DMEM) containing 2 mM L-glutamine, 25 mM HEPES,
4.5 g/L glucose, penicillin (100 U/ml), streptomycin (100
μg/ml), and 18% fetal bovine serum (FBS), and counted.
The cell viability was over 95% as determined by the
trypan blue staining. Cells were cultured on 10 cm dishes
(Costar) at a density of 3 × 106 cells/dish (for extraction of
total protein and total RNA) or 6-well culture plates (Cos-
tar) at a density of 2 × 105 cells/well (for endocytosis
experiments). The cells were incubated at 37°C in a
humidified atmosphere containing 5% CO2 in air. The
following day, the cells were washed twice in HBSS to
remove non-adherent cells and fresh growth medium
containing 18% FBS was added. One day later (day 2), the
cells were washed again as above and incubated with
growth medium containing 10% FBS for the next 5 days.
In some experiments, the cells were activated for 8 days in
75 cm flasks, trypsinized, recovered by centrifugation and
then sub-cultured (first passage) in 10 cm dishes or 6-well
plates and used after 3 to 5 days.
Oil Red-O staining
Oil Red-O staining was used to detect cytoplasmic lipid
droplets. Cells were washed with phosphate-buffered
saline (PBS), pH 7.4, and fixed in 1% paraformaldehyde
at room temperature for 60 min. The cells were then
washed with 50% isopropanol and stained with 0.3% Oil
Red-O for 10 min at room temperature, washed with PBS,
and then the nuclei were stained with hematoxylin for 2
min. Finally, the cells were washed with PBS and fixed
with 1% PFA before they were photographed. Micro-
photographs were taken using a light microscope (Leica
DMIL) connected to a digital camera (Wetzler GmbH).
Labelling of denatured collagen
Radio-labelled tyramine cellobiose (125I-TC) was pre-
pared by reacting TC with Na125I (Perkin-Elmer) in
Iodogen tubes (Pierce) and was then coupled covalently
to heat-denatured collagen (5 mg in 500 μl borate buffer,
pH 9.4) after activating the 125I-TC with the cross-linkingPage 7 of 11
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Expression of Endo180 protein and mRNA by four established HSC lines from three different speciesFigure 4
Expression of Endo180 protein and mRNA by four established HSC lines from three different species. Detection 
of Endo180 and β-actin proteins (A) and mRNAs (B) was performed as described in Figure 2. Results are representative of 
three (A) or two (B) experiments. (C) Uptake and degradation of denatured collagen by different HSC lines. Cells were grown 
in 6-well plates, washed, pre-incubation for 45 min at 37°C, and then incubated for 2 h at 37°C with 10 μg/ml 125I-TC-collagen. 
Experimental procedure is as in the legend to Figure 3. (D) The calculated percentage of internalized 125I-TC-collagen degraded 
by different HSC lines. Results are shown as means ± SD for triplicate wells and are representative for at least two similar 
experiments. Cells used from a new passage was treated as a separate experiment. Data are normalized for cell number.
BMC Cell Biology 2009, 10:39 http://www.biomedcentral.com/1471-2121/10/39agent cyanuric chloride, essentially as described by Pitt-
man et al [58]. The labelled protein (125I-TC-collagen) was
dialyzed against PBS using 10000 Da dialysis cassettes
(Pierce Biotechnology) to remove non-coupled 125I-TC.
Uptake and degradation experiments
Cells were washed three times with HBSS and then 1 ml
DMEM containing 1% bovine serum albumin (BSA) was
added. After pre-incubation for 45 min at 37°C, cells were
incubated with 125I-TC-collagen at 37°C. For experiments
where inhibitors were used, cells were either treated with
inhibitor or control amounts of vehicle (DMSO) during
the last 15 min of the pre-incubation period. At the end of
the incubation period, the medium was removed and the
cells were washed three times with ice-cold PBS, scraped
in lysis buffer (0.1% SDS, 0.1 N NaOH), transferred to
tubes and then precipitated with trichloracetic acid and
BSA at final concentrations of 10% and 0.5%, respec-
tively. Cell lysates were kept on ice for 15 min and centri-
fuged to separate acid-soluble fraction from the acid-
precipitable fraction. Cell-associated acid-soluble and
acid-precipitable radioactivities were measured using a γ
counter. It should be noted that the 125I-TC moiety
formed after degradation of 125I-TC-collagen is not
released to the medium but remains trapped in degrada-
tive compartments [58]. Total uptake was calculated by
subtracting radioactivity bound to the cell surface at 4°C
from total cell-associated radioactivity measured at 37°C
and expressed as the sum of acid-precipitable and acid-
soluble radioactivity. Radioactivity bound to control wells
(wells containing no cells) was less than 0.1% of the total
radioactivity added to the medium. On each of days 1, 2,
and 3 cells were counted directly in duplicate wells under
an inverted microscope. On days 4, 5, 6, and 7 duplicate
wells were trypsinized and cell number determined by use
of a hemocytometer.
Western blot analysis
At different time points, cultured HSCs were washed three
times with PBS, scraped, spun down, and cell pellets were
frozen at -20°C until preparation of total protein. Total
protein was prepared from frozen cell pellets by addition
of sample-loading buffer (Tris buffer pH 6.8, 2% Sodium
dodecyl sulfate (SDS), and 10% sucrose) containing pro-
tease inhibitors. In some experiments cells were washed
and lysed directly in sample-loading buffer containing
protease inhibitors and stored at -20°C. Cell lysates were
kept on ice for 30 min with occasional vortexing, boiled
for 7 min, centrifuged, and protein concentration in the
clarified lysates was determined using the BCA Protein
Assay kit (Pierce). Equal amounts of protein (30–50 μg)
in cell lysates were separated by 7.5% SDS-polyacrylamide
gel electrophoresis (SDS-PAGE) under non-reducing con-
ditions and electrotransferred to a polyvinylidine difluo-
ride membrane (Millipore). The membrane was blocked
in PBS containing 0.1% (v/v) Tween-20 (PBS-Tween) and
5% skim milk for 1 h at room temperature and then blot-
ted with rabbit anti-Endo180 polyclonal antibody for 1 h.
After several washes with PBS-Tween, the membrane was
incubated for 1 h with horseradish peroxidase (HRP)-con-
jugated anti-rabbit IgG to detect bound anti-Endo180.
The membrane was washed with PBS-Tween and second-
ary HRP-conjugated antibody was visualized by ECL
detection system (GE Healthcare) and exposed to film.
The membrane was stripped for re-blotting with β-actin
and one or two marker proteins.
Reverse-transcriptase polymerase chain reaction (RT-
PCR)
At different time points, cultured HSCs were washed three
times with PBS, scraped, spun down, and cell pellets were
frozen at -20°C until preparation of total RNA. Total RNA
was extracted from frozen cell pellets using Versagene
RNA Cell Kit (Gentra Systems) according to the manufac-
turer's instruction. One microgram total RNA was reverse
transcribed using SuperScript II RNase H- Reverse Tran-
scriptase (Invitrogen). After cDNA synthesis, the cDNA
mixture was used as template for PCR. Routine PCR was
performed using DyNAzyme (Finnzymes) and the prim-
ers (rat/mouse Endo180 forward 5'-CAC GGG AAG CCG
TGT ACT AT-3' and reverse 5'-CCT CCA GGA CAG TGT
GGA TT-3', human Endo180 forward 5'-GGA ACC CAA
CAT CTT CCT CA-3' and reverse 5'-CCG GTC ACA CTC
ATA CAT GC-3', and β-actin forward 5'-AGC CAT GTA
CGT AGC CAT CC-3' and reverse 5'-TCT CAG CTG TGG
TGG TGA AG-3') were designed by the Primer 3 Output
program http://frodo.wi.mit.edu/cgi-bin/primer3/
primer3_www.cgi.
Cell lines
LX-2, a human HSC line, was provided by Dr. Scott L.
Friedman (Mount Sinai School of Medicine, New York).
The murine M1-4 HSC line was provided by Dr. Wolfgang
Mikulits (Institute of Cancer Research, Medical University
of Vienna, Austria). The rat HSC lines, BSC and MFBY2,
were provided by Dr. Hidekazu Tsukamoto (Keck School
of Medicine, University of Southern California, Los Ange-
les) and Dr. Sato Kenzo (School of Life Science, Tottori
University Faculty of Medicine, Japan), respectively. The
murine and rat HSC lines were cultured in DMEM con-
taining 10% FBS (Gibco BRL, Invitrogen) and kept at
37°C as described for primary cultures. LX-2 cell line was
maintained under identical conditions but in Medium
199 instead of DMEM. For Western blotting and RT-PCR
analyses, the cells were cultured to 80–90% confluency in
10 cm dishes and harvested as described for primary cul-
ture HSCs. For endocytosis, cells were cultured in 12-well
plates at 1 × 105 cells per well twelve hours before the start
of experiments and endocytosis was measured as
described above. Duplicate wells were trypsinized and cellPage 9 of 11
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tometer.
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